Projets primés en 2023

  1. S100A4 in atherosclerosis: from smooth muscle cell to immune regulation
    Dr Pascal Azar
  2. Is androgen deprivation therapy associated with increased risk of Alzeimer’s disease and neurodegeneration
    Dr Kelly Ceyzeriat
  3. Impact of nociceptors on tumor-associated lymph vessels
    Dr Laure Garnier
  4. Molecular and functional interactions between circadian clocks and mRNA degradation in pancreatic islet cells in the context of diabetes
    Dr Georgia Katsioudi
  5. Clinical relevance of fundamental findings in prostate cancer
    Dr Julie Terzic

Projets primés 2022

  1. Tumor niche vascular dysfunction and fibrosis in cancers: relevance of the regulation of integrin b1 function by the acetyltransferase aTAT1
    Dr Adama Sidibe  Dept de Physiologie cellulaire et métabolisme,  Centre Médical Universitaire de Genève
  2. Multiplex imaging analysis of the tumor-immune micro-environment in rectal cancer
    Dr Claudia Corro Service d’Oncologie Hôpitaux Universitaires de Genève
  3. Exploratory analysis of the biological effects of an online mindfulness-based cancer-recovery (MBCR) program for women with gynecological cancer
    Dr Marie-Estelle Gaignard Service d’Oncologie, Hôpitaux Universitaires de Genève
  4. Elucidating the role of T regulatory (Treg) cells in NAFLD/NASH
    Dr Karim Gariani  Service d’endocrinologie, Hôpitaux Universitaires de Genève
  5. Impac of tumor micro-environment on lymphatic vessel features and immunomodulatory function
    Dr Laure Garnier  Dept de Pathologie, Centre Médical Universitaire de Genève
  6. Recherche de nouvelles vulnérabilités des cellules souches leucémiques par des approches de criblages pharmacologiques et génétiques
    Dr Clément Larrue  Service d’Hématologie,  Hôpitaux Universitaires de Genève